The European Medicines Agency has approved the Pfizer-BioNTech COVID-19 vaccine for use in the European Union's 27 member countries.
The vaccine rollout program could start in less than a week.
The European regulator has been under pressure since the UK, Canada and the US granted approval for use of the vaccine.